3 completed, 2 not yet recruiting. 2 Phase 4, 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Tacrolimus 0.1%: new trials by email Literature Review of Tacrolimus 0.1% trials Research Report on Tacrolimus 0.1%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis Crisaborole 2%, Tacrolimus 0.1% - Atopic Dermatitis, Atopic Dermatitis (AD) | Phase 3 | Not yet recruiting | Shalamar Institute of Health Sciences | 66 | 2026-06-01 | 2025-09-09 |
| Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis Crisaborole 2% Topical Application Ointment [EUCRISA, tacrolimus 0.1% - Atopic Dermatitis | Phase 4 | Not yet recruiting | Hayat Abad Medical Complex, Peshawar | 148 | 2026-03-01 | 2026-03-02 |
| EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS Tested Emollient RV5258A, tacrolimus 0.1% - Atopic Dermatitis (AD) | Not applicable | Completed | Pierre Fabre Dermo Cosmetique | 33 | 2025-11-03 | 2026-09-14 |
| Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus Tacrolimus 0.1%, Clobetasol 0.05% - Oral Lichen Planus | Phase 2 | Completed | University of Peradeniya | 68 | 2014-06-01 | 2016-04-20 |
| Protopic Ointment in Adult Atopic Eczema of the Face tacrolimus 0.1%, fluticasone 0.005 % - Dermatitis, Atopic | Phase 4 | Completed | Astellas Pharma Inc | 577 | 2004-02-01 | 2014-09-01 |
Dermatitis, Atopic (4) · Eczema (1) · Facies (1) · Lichen Planus, Oral (1) · Pruritus (1)
Astellas Pharma Inc (1) · Hayat Abad Medical Complex, Peshawar (1) · Pierre Fabre Dermo Cosmetique (1) · Shalamar Institute of Health Sciences (1) · University of Peradeniya (1)
Pakistan (2) · France (1) · Poland (1)